HKD 1.16
(0.0%)
Year | EBITDA | EBITDA Growth |
---|---|---|
2023 | -208.36 Million CNY | 87.74% |
2022 | -1.58 Billion CNY | 58.21% |
2021 | -4.05 Billion CNY | -42.19% |
2020 | -2.85 Billion CNY | -420.19% |
2019 | -548.89 Million CNY | -440.8% |
2018 | -101.49 Million CNY | 0.0% |
Year | EBITDA | EBITDA Growth |
---|---|---|
2024 Q2 | -34.49 Million HKD | 0.15% |
2024 Q1 | -34.78 Million HKD | 55.21% |
2023 Q3 | -77.23 Million HKD | -52.02% |
2023 FY | - CNY | 87.74% |
2023 Q2 | -50.8 Million HKD | 5.52% |
2023 Q1 | -53.76 Million HKD | 68.57% |
2023 Q4 | -79.21 Million HKD | -2.57% |
2022 Q2 | -275.79 Million HKD | 0.0% |
2022 FY | - CNY | 58.21% |
2022 Q4 | -171.07 Million HKD | -2.58% |
2022 Q3 | -166.78 Million HKD | 39.53% |
2021 FY | - CNY | -42.19% |
2021 Q1 | -143.77 Million HKD | 0.0% |
2020 FY | - CNY | -420.19% |
2019 FY | - CNY | -440.8% |
2018 FY | - CNY | 0.0% |
Name | EBITDA | EBITDA Difference |
---|---|---|
Wanjia Group Holdings Limited | -29.02 Million HKD | -617.881% |
China Health Group Limited | -37.41 Million HKD | -456.843% |
Tai United Holdings Limited | -1.18 Billion HKD | 82.419% |